Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Michelle Gilson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- South Cone Investments Limited Partnership - $15.71M of RANI open-market activity in the last 12 months
- Mir A. Imran - $1.29M of RANI open-market activity in the last 12 months
- Talat Imran - $25K of RANI open-market activity in the last 12 months
- Alireza Javadi - $301 of RANI open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Michelle Gilson?
Michelle Gilson is a corporate insider, tracked as Director of Rani Therapeutics Holdings, Inc. (RANI). InsiderAlpha holds 12 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Michelle Gilson submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Michelle Gilson been buying or selling stock?
Recorded transactions: 0 open-market purchases and 16 open-market sales ($5.03M) across all tracked filings.
Where can I see all of Michelle Gilson's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Michelle Gilson and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
